Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021500
Filing Date
2023-05-12
Accepted
2023-05-12 07:30:52
Documents
92
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-20230331.htm   iXBRL 10-Q 3455427
2 EX-31.1 itrm-ex31_1.htm EX-31.1 21625
3 EX-31.2 itrm-ex31_2.htm EX-31.2 21969
4 EX-32.1 itrm-ex32_1.htm EX-32.1 13022
5 EX-32.2 itrm-ex32_2.htm EX-32.2 13014
  Complete submission text file 0000950170-23-021500.txt   13552821

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itrm-20230331_lab.xml EX-101.LAB 640870
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itrm-20230331_cal.xml EX-101.CAL 59122
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itrm-20230331_def.xml EX-101.DEF 364447
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itrm-20230331.xsd EX-101.SCH 90792
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itrm-20230331_pre.xml EX-101.PRE 519373
86 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20230331_htm.xml XML 2829577
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 23913169
SIC: 2834 Pharmaceutical Preparations